CADILLAC FORMULA 1® TEAM WELCOMES VIATRIS AS OFFICIAL GLOBAL PHARMACEUTICAL PARTNER

PR Newswire

INDIANAPOLIS and PITTSBURGH, Nov. 16, 2026

Multiyear partnership brings together a U.S.-based global healthcare company and America's new Formula 1® team

INDIANAPOLIS and PITTSBURGH, Nov. 16, 2026 /PRNewswire/ -- The Cadillac Formula 1® Team and Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced a multiyear partnership that makes Viatris the team's Official Global Pharmaceutical Partner, beginning in 2027.

The partnership connects motorsport and medicine, two industries where precision, reliability and performance matter. It brings together two American companies with ambitious visions for the future and a shared belief in the power of ingenuity to make them a reality.

As the Cadillac Formula 1® Team establishes itself on the global Formula 1® stage, taking on long-established competitors, Viatris is entering a new phase of its evolution, pursuing new opportunities and continuing to make a difference for patients around the world.

The announcement comes as Viatris marks its sixth anniversary. Since its formation in 2020, Viatris has delivered medicines to patients in more than 165 countries and territories through a diverse portfolio of generics, value-added medicines, established brands and innovative medicines that address areas of significant unmet medical need.

Both organizations operate on a global scale and work on demanding timelines. Every race weekend, the Cadillac Formula 1® Team moves people, cars and equipment across continents. Every day, Viatris works to bring medicines to patients around the world, advancing its mission to empower people worldwide to live healthier at every stage of life.

Viatris joins the Cadillac Formula 1® Team family of global companies that have partnered with the team in its first season. Those partnerships are part of a long-term commercial program that will grow as the team opens its new headquarters in Fishers, Indiana, in 2027, builds its fan base in the U.S. and around the world, and becomes a full-works American team by the end of the decade.

"Viatris makes medicines that people count on every day, and Formula 1® gives them one of the biggest stages in the world to show how they do it," said Tyler Epp, Global Head of Commercial Strategy, Cadillac Formula 1® Team. "For a team in its first season, having a global company like Viatris choose to partner with the Cadillac Formula 1® Team says a lot about where we're headed. We are thankful for the trust that Viatris has placed in our team and cannot wait to grow with them into the future."

"What attracted us to the Cadillac Formula 1® Team is the ambition and ingenuity behind what they're building," said Andrew Enrietti, Chief Administrative and Transformation Officer of Viatris. "At Viatris, we're focused on executing our strategy and continuing to find ways to make a difference for patients around the world. We share a determination to embrace new opportunities, bring talented people and different perspectives together, and turn bold ideas into meaningful progress. This partnership gives us an exciting opportunity to showcase that shared spirit while introducing Viatris to new audiences around the world."

The partnership begins with the 2027 season, the Cadillac Formula 1® Team's second season on the grid.

Excel Sports Management, the agency of record for the Cadillac Formula 1® Team, supported partnership discussions between Viatris and the team.

About Cadillac Formula 1® Team
The Cadillac Formula 1® Team is a specialist motor racing team competing in the FIA Formula 1® World Championship. Backed by TWG Motorsports and General Motors, the team has operations in Indianapolis, Indiana (USA); Charlotte, North Carolina (USA); and Silverstone, Northamptonshire (UK). With the confidence to dream big and the passion to deliver, the Cadillac Formula 1® Team is building everything from the ground up — from high-performance race cars to an inclusive, values-driven culture. The team made its Formula 1® debut in 2026.

About Viatris 
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.

About TWG Motorsports
TWG Motorsports is the motorsports entity of TWG Global, unifying a robust racing portfolio across the world's biggest stages in Formula 1®, INDYCAR, Formula E, IMSA and NASCAR. With strategic partnerships that include General Motors on the Cadillac Formula 1® Team and ownership of Andretti Global, Wayne Taylor Racing and Spire Motorsports, TWG Motorsports combines deep technical expertise, proven competitive excellence and industry-leading business acumen. TWG Motorsports is committed to innovating, growing and winning at the highest levels of the sport. Learn more at TWGMotorsports.com.

About General Motors
General Motors (NYSE: GM) is driving the future of transportation, leveraging advanced technology to build safer, smarter, and lower-emission cars, trucks and SUVs. GM's Buick, Cadillac, Chevrolet and GMC brands offer a broad portfolio of innovative gasoline-powered vehicles and the industry's widest range of EVs, as we move to an all-electric future. Learn more at GM.com.

Viatris OUS Logo

Cadillac CF1

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cadillac-formula-1-team-welcomes-viatris-as-official-global-pharmaceutical-partner-302939878.html

SOURCE Viatris Inc.